Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Acrux Limited ( (AU:ACR) ).
Acrux Limited announced a change in the interests of their director, Geoffrey Brooke, regarding company securities. Dr. Brooke acquired 285,714 ordinary shares through a Share Placement approved at an EGM, under the same terms as other participants, reflecting continued confidence in the company’s strategic initiatives.
More about Acrux Limited
Acrux Limited operates in the pharmaceutical industry, focusing on the development and commercialization of pharmaceutical products.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.86M
Learn more about ACR stock on TipRanks’ Stock Analysis page.
